Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy

Pompe disease, also known as glycogen storage disease Type II, is a lysosomal storage disorder caused by α-glucosidase deficiency. In general, the clinical spectrum varies with respect to the age of onset, residual enzyme activity and organ involvement. Infantile onset disease has two subtypes: cl...

Full description

Bibliographic Details
Main Authors: Sanjay Kumar, Amit Kumar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/9849/20756_CE[Ra1]_F(DK)_PF1(RB_RK)_PFA(RB_SS).pdf
_version_ 1818901797388943360
author Sanjay Kumar
Amit Kumar
author_facet Sanjay Kumar
Amit Kumar
author_sort Sanjay Kumar
collection DOAJ
description Pompe disease, also known as glycogen storage disease Type II, is a lysosomal storage disorder caused by α-glucosidase deficiency. In general, the clinical spectrum varies with respect to the age of onset, residual enzyme activity and organ involvement. Infantile onset disease has two subtypes: classical and non-classical (atypical). This case report describes the case of a newborn who presented with generalized hypotonia and elevated serum enzyme levels of aspartate aminotransferase 93 IU/L, lactate dehydrogenase 888 IU/L and creatine kinase 670 µg/L. The electrocardiogram showed short PR interval with large QRS complexes with echocardiography suggesting evidence of left ventricular hypertrophy with infiltration in its walls. On the basis of the clinical signs and laboratory results, dried blood spots from the baby were tested to determine the acid α-glucosidase (GAA) activity, and the result confirmed that the GAA activity was only 1.42 units, normal range 5.5 to 29.6 units, leading to a diagnosis of Pompe disease (atypical infantile). Recognizing this disease and initiating enzyme replacement therapy in infants at the earliest can improve the quality of life of patients.
first_indexed 2024-12-19T20:25:28Z
format Article
id doaj.art-586d6ddc76f946f7a5d557461fd7c792
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-19T20:25:28Z
publishDate 2017-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-586d6ddc76f946f7a5d557461fd7c7922022-12-21T20:06:50ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2017-05-01115SD01SD0210.7860/JCDR/2017/20756.9849Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular HypertrophySanjay Kumar0Amit Kumar1Senior Resident, Department of Paediatrics, AIIMS, New Delhi, India.Senior Resident, Department of Paediatrics, VMMC and Safdarjung Hospital, New Delhi, India.Pompe disease, also known as glycogen storage disease Type II, is a lysosomal storage disorder caused by α-glucosidase deficiency. In general, the clinical spectrum varies with respect to the age of onset, residual enzyme activity and organ involvement. Infantile onset disease has two subtypes: classical and non-classical (atypical). This case report describes the case of a newborn who presented with generalized hypotonia and elevated serum enzyme levels of aspartate aminotransferase 93 IU/L, lactate dehydrogenase 888 IU/L and creatine kinase 670 µg/L. The electrocardiogram showed short PR interval with large QRS complexes with echocardiography suggesting evidence of left ventricular hypertrophy with infiltration in its walls. On the basis of the clinical signs and laboratory results, dried blood spots from the baby were tested to determine the acid α-glucosidase (GAA) activity, and the result confirmed that the GAA activity was only 1.42 units, normal range 5.5 to 29.6 units, leading to a diagnosis of Pompe disease (atypical infantile). Recognizing this disease and initiating enzyme replacement therapy in infants at the earliest can improve the quality of life of patients.https://jcdr.net/articles/PDF/9849/20756_CE[Ra1]_F(DK)_PF1(RB_RK)_PFA(RB_SS).pdfenzyme replacement therapylysosomesnon-classical (atypical)
spellingShingle Sanjay Kumar
Amit Kumar
Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
Journal of Clinical and Diagnostic Research
enzyme replacement therapy
lysosomes
non-classical (atypical)
title Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
title_full Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
title_fullStr Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
title_full_unstemmed Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
title_short Unusual Presentation of Atypical Infantile Pompe Disease in the Newborn Period with Left Ventricular Hypertrophy
title_sort unusual presentation of atypical infantile pompe disease in the newborn period with left ventricular hypertrophy
topic enzyme replacement therapy
lysosomes
non-classical (atypical)
url https://jcdr.net/articles/PDF/9849/20756_CE[Ra1]_F(DK)_PF1(RB_RK)_PFA(RB_SS).pdf
work_keys_str_mv AT sanjaykumar unusualpresentationofatypicalinfantilepompediseaseinthenewbornperiodwithleftventricularhypertrophy
AT amitkumar unusualpresentationofatypicalinfantilepompediseaseinthenewbornperiodwithleftventricularhypertrophy